EAACI Congress 2023
BackAdvances in allergen Immunotherapy II
Saturday 10 Jun, 08:30 AM -
10:00 AM CEST
Hall Y 03+04
ORAL Session
08:42
Long-term, real-world effectiveness of allergy immunotherapy in younger children Subgroup analysis of the REACT-study
08:42
Uncovering molecular signatures of positive peanut-oral immunotherapy response through transcriptome and methylome profiling of peripheral blood monocytes
08:54
Long-term, real-world effectiveness of allergy immunotherapy in children with allergic rhinitis and pre-existing asthma. Subgroup analysis of the REACT-study
09:18
A randomized, double-blind placebo-controlled phase III study with mannan-conjugated birch pollen allergoids administered subcutaneously to allergic patients
09:18
Steroid sparing effect of 300IR house dust mite sublingual immunotherapy tablet in house dust mite allergic rhinitis patients
09:42
Consistent reduction in symptom and medication scores already in the first week of the first pollen season in adults and children treated with SQ SLIT-tablets
